II. Precautions: CYP2C9 Deficiency related to Warfarin toxicity
- Higher risk for Warfarin toxicity and bleeding complications
- Start with lower doses
- Reaching a steady-state INR on Warfarin requires >3 months
- Voora (2005) Thromb Haemost 93:700-5 [PubMed]
III. Interactions: Metabolized by CYP2C9 (Substrates)
- Cardiopulmonary Drugs
- Carvedilol (Coreg)
- Tolbutamide
- Angiotensin Receptor Blockers (ARBs) affected
- ARBs not affected by Cytochrome P450 System
- Miscellaneous
IV. Interactions: Inhibitor of CYP2C9
- Neuropsychiatric drugs
- Cardiopulmonary Drugs
-
Antibiotics and Antifungals
- Fluconazole (Diflucan)
- Ketoconazole
- Metronidazole (Flagyl)
- Ritonavir
- Trimethoprim-sulfamethoxazole (Septra)
V. Interactions: Inducer of CYP2C9
- Neuropsychiatric drugs
- Antibiotics